APA (7th ed.) Citation

Sviridenko, A., Boehm, A., di Santo, G., Uprimny, C., Nilica, B., Fritz, J., . . . Virgolini, I. (2022). Enhancing clinical diagnosis for patients with persistent pulmonary abnormalities after COVID-19 infection: The potential benefit of 68 Ga-FAPI PET/CT. Clinical nuclear medicine, 47(12), . https://doi.org/10.1097/RLU.0000000000004437

Chicago Style (17th ed.) Citation

Sviridenko, Anna, et al. "Enhancing Clinical Diagnosis for Patients with Persistent Pulmonary Abnormalities After COVID-19 Infection: The Potential Benefit of 68 Ga-FAPI PET/CT." Clinical Nuclear Medicine 47, no. 12 (2022). https://doi.org/10.1097/RLU.0000000000004437.

MLA (9th ed.) Citation

Sviridenko, Anna, et al. "Enhancing Clinical Diagnosis for Patients with Persistent Pulmonary Abnormalities After COVID-19 Infection: The Potential Benefit of 68 Ga-FAPI PET/CT." Clinical Nuclear Medicine, vol. 47, no. 12, 2022, https://doi.org/10.1097/RLU.0000000000004437.